Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38MAPK.

Meihua Bao,Yijia Lou
DOI: https://doi.org/10.1016/j.ejphar.2006.07.021
IF: 5.195
2006-01-01
European Journal of Pharmacology
Abstract:The present investigation was undertaken to determine the protective effects of isorhamnetin on endothelial cell line EA.hy926 injuries induced by oxidized low-density lipoprotein (ox-LDL) and to uncover some of the underlying mechanisms of these effects.
What problem does this paper attempt to address?